Steve Haakenson
Executive Director @ Biosciences Research and Commercialization Center (BRCC)
Grand Rapids, United States
Steve Haakenson is a seed investor at Biosciences Research and Commercialization Center (BRCC) in Grand Rapids focused on Health Care and Hospital. Steve Haakenson
- Total investments:
- 4
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Steve Haakenson invests in
Stages Steve Haakenson invests in
Countries Steve Haakenson invests in
Investment Focus
Industry
- Health Care 2 (50%)
- Hospital 1 (25%)
- Biotechnology 1 (25%)
- Medical Device 1 (25%)
- Clinical Trials 1 (25%)
Stage
- Seed 1 (25%)
- Funding Round 1 (25%)
Country
- United States 1 (25%)
- Russian Federation 1 (25%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
Cleanliness Analytics - helping healthcare systems prevent infections in their facilities | $750K / May 29, 2026 | |
|
|
Cleanliness Analytics - helping healthcare systems prevent infections in their facilities | $1.4M / Seed / Nov 03, 2023 | |
|
|
GreenMark is a healthcare company providing health-based benefits using nanoparticles. The company develops technologies that involve biopolymer nanoparticles produced from natural starch as a raw material. | $670K / Seed / Mar 20, 2019 | |
|
|
GreenMark is a healthcare company providing health-based benefits using nanoparticles. The company develops technologies that involve biopolymer nanoparticles produced from natural starch as a raw material. | $500K / Seed / Jun 29, 2018 |
Co-Investors
About Biosciences Research and Commercialization Center (BRCC)
The BRCC, established in 2003 by the Michigan Legislature, is located at Western Michigan University and is perfectly positioned to access the wealth of scientific talent and pharmaceutical commercialization expertise that is part of Kalamazoo’s heritage. Long-time home to such industry giants as the Upjohn Co., Richard-Allan Scientific, StrykerCorp. and Pfizer Inc., Kalamazoo offers a forward-looking, entrepreneurial business climate and a growing reputation among venture capitalists seeking to invest in life sciences discoveries and promising business ventures. Their customers are entrepreneurs, scientists, University Technology Transfer offices and corporate clients.The BRCC provides startup and gap funding to promising Michigan-based life sciences and medical device ventures entering the commercialization phase of development.
Biosciences Research and Commercialization Center (BRCC) Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Steve Haakenson
Executive Director
|
|||
4 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Steve Haakenson invest in?
Steve Haakenson invests primarily in Health Care, Hospital and Biotechnology startups, most often at Seed and Funding Round stage. Most of the 4 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Steve Haakenson last invest?
The most recent investment recorded for Steve Haakenson closed in May 2026. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!